Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.302 +0.002 (+0.03%)
Delayed Quote Updated: 3:28 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
24 25 Next >
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference
Via Investor Brand Network
News headline image
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Via ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
Via Investor Brand Network
News headline image
CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
Via ACCESSWIRE
News headline image
CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment
Via ACCESSWIRE
News headline image
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
Via ACCESSWIRE
News headline image
What's Going On With CNS Pharmaceuticals Stock Tuesday? ↗
CNS Pharmaceuticals entered into a exclusive license agreement with Cortice Biosciences. 
Via Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Upcoming Virtual Investor CEO Connect Segment
Via Investor Brand Network
Scientists Find Way to Boost Natural Killer Cells Targeting Pediatric Brain Cancer
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results
Via Investor Brand Network
News headline image
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q2 2024 ↗
CNS Pharmaceuticals just reported results for the second quarter of 2024. 
Via InvestorPlace
News headline image
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series
Via ACCESSWIRE
Study Uncovers How Brain Tumors Evolve During Treatment
Via Investor Brand Network
News headline image
Why Kellanova Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Microsoft Office Outage: Microsoft Investigates Applications, Services Issue ↗
A Microsoft Office outage has workers annoyed as its causing problems with them being able to use the company's services. 
Via InvestorPlace
News headline image
SOUN Stock Alert: SoundHound Expands AI Rollout with Stellantis ↗
SoundHound AI stock is up on Tuesday as SOUN investors react well to the company's voice assistant coming to Stellantis vehicles. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today? ↗
CNS Pharmaceuticals stock is falling hard on Tuesday as CNSP investors aren't happy about its latest license expansion. 
Via InvestorPlace
News headline image
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM
Via Investor Brand Network
Topics Intellectual Property
News headline image
Dow Jumps 200 Points; Pfizer Earnings Top Views ↗
 
Via Benzinga
Topics Stocks
News headline image
CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies
Via ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CMO to Present Poster at Upcoming SNO/ASCO CNS Cancer Conference
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference
Via ACCESSWIRE
Study Uncovers Ancient Egyptian Attempts to Surgically Remove Brain Cancer
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Exec to Present at Upcoming Virtual Investor Closing Bell Series
Via Investor Brand Network
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are a hot topic on Thursday and we have breakdowns of all the latest news affecting shares this morning! 
Via InvestorPlace
Research Identifies How Glioblastoma Develops Resistance to Immunotherapy
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enters Securities Purchase Agreements Worth Estimated $1.98M
Via Investor Brand Network
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.